Moreover, QUR and paclitaxel had enhanced the multi-drug resistance in breast cancer MCF-7/ADR cell lines and in vivo by decreasing P-gp expression and inhibiting of the cellular paclitaxel reflux [271]. Here, PGP is linked to breast carcinoma.